J Wrist Surg 2023; 12(02): 135-142
DOI: 10.1055/s-0042-1760124
Scientific Article

Comparison of Clinical and Functional Outcomes after Platelet-Rich Plasma Injection and Corticosteroid Injection for the Treatment of de Quervain's Tenosynovitis

1   Central Institute of Orthopaedics, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
,
1   Central Institute of Orthopaedics, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
,
1   Central Institute of Orthopaedics, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
,
Loveneesh G. Krishna
1   Central Institute of Orthopaedics, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
,
Vinod Kumar Sharma
1   Central Institute of Orthopaedics, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
› Author Affiliations
Funding None.

Abstract

Background Platelet-rich plasma (PRP) has local anti-inflammatory actions, which is being used as a treatment in various tendinopathies.

Purpose The aim of the study is to compare the clinical results of PRP injection and corticosteroid injection in the management of de Quervain's tenosynovitis (DQTSV).

Patients and Methods In this prospective study, 60 patients of DQTSV, fulfilling the predefined inclusion and exclusion criteria, were randomised into two groups. In group 1 (n = 30), patients received a single injection of autologous PRP and in group 2 (n = 30) they received a single injection of corticosteroid (methylprednisolone). All patients were followed up at 1 month, 3 months, 6 months, and 1 year for evaluation by Finkelstein test, visual analogue scale (VAS), DASH (Disabilities of the Arm, Shoulder and Hand) score, and Modified Mayo Wrist score (MMWS).

Results In both the groups improvement occurred in Finkelstein test, VAS score, DASH score, and MMWS which were found to be statistically significant at all points of follow-ups when compared to the pre-intervention values. Comparison of scores between the two groups did not show any statistical significance. No complications were reported in PRP group. Statistically significant complications (p-value = 0.026) like subcutaneous fat atrophy, depigmentation, and temporary increase in pain were seen in eight patients in the corticosteroid group with an overall complication rate of 26.67%.

Conclusion Both the modalities are equally effective in the management of DQTSV remittance. PRP is equally effective as corticosteroid in reducing symptoms of first dorsal compartment stenosing tenosynovitis. PRP may have a lower complication profile, however, this benefit should be weighed against the slight increase in cost and time of PRP preparation and injection.

Level of Evidence Level 2, prospective comparative study.

Statement of Human and Animal Rights-

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5).


Statement of Informed Consent

All patients enrolled in this study gave informed consent to participate and no identifying factors were used.


Availability of Data and Material

Data was collected from the patients reported in our hospital.


Code Availability

Not applicable.




Publication History

Received: 02 May 2022

Accepted: 18 November 2022

Article published online:
29 December 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Viikari-Juntura E. Tenosynovitis, peritendinitis and the tennis elbow syndrome. Scand J Work Environ Health 1984; 10 (Spec no. 6): 443-449
  • 2 de Quervain F. On a form of chronic tendovaginitis by Dr. Fritz de Quervain in la Chaux-de-Fonds. 1895. Am J Orthop 1997; 26 (09) 641-644
  • 3 Finkelstein H. Stenosing tendovaginitis at the radial styloid process. J Bone Joint Surg Am 1930; 12: 509-540
  • 4 Zingas C, Failla JM, Van Holsbeeck M. Injection accuracy and clinical relief of de Quervain's tendinitis. J Hand Surg Am 1998; 23 (01) 89-96
  • 5 Ilyas AM. Nonsurgical treatment for de Quervain's tenosynovitis. J Hand Surg Am 2009; 34 (05) 928-929
  • 6 da Silva JBG, Batigália F. Acupuncture in De Quervain's disease: a treatment proposal. Acupunct Med 2014; 32 (01) 70-72
  • 7 Moretti M. Effectiveness of oxygen-ozone and hyaluronic acid injections in De Quervain's syndrome. Int J Ozone Ther 2012; 11 (01) 31-33
  • 8 Peck E, Ely E. Successful treatment of de Quervain tenosynovitis with ultrasound-guided percutaneous needle tenotomy and platelet-rich plasma injection: a case presentation. PM R 2013; 5 (05) 438-441
  • 9 Tseng V, Ibrahim V, Yokel NR. Prolotherapy for dequervain's tenosynovitis/tendonosis: a case report. PM R 2012; 4 (10) S275
  • 10 Peters-Veluthamaningal C, Winters JC, Groenier KH, Meyboom-DeJong B. Randomised controlled trial of local corticosteroid injections for de Quervain's tenosynovitis in general practice. BMC Musculoskelet Disord 2009; 10: 131
  • 11 Cardone DA, Tallia AF. Joint and soft tissue injection. Am Fam Physician 2002; 66 (02) 283-288
  • 12 Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med 2011; 39 (06) 1200-1208
  • 13 Soomekh DJ. Current concepts for the use of platelet-rich plasma in the foot and ankle. Clin Podiatr Med Surg 2011; 28 (01) 155-170
  • 14 Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med 2008; 1 (3-4): 165-174
  • 15 Rha DW, Park GY, Kim YK, Kim MT, Lee SC. Comparison of the therapeutic effects of ultrasound-guided platelet-rich plasma injection and dry needling in rotator cuff disease: a randomized controlled trial. Clin Rehabil 2013; 27 (02) 113-122
  • 16 El Sheikh A, Mahmoud SA, El-Rahim MAbd. The role of platelet rich plasma in comparison with corticosteroids in the treatment of De Quervain tenosynovitis. Med J Cairo Univ 2020; 88: 141-148
  • 17 Chaffee A, Yakuboff M, Tanabe T. Responsiveness of the VAS and McGill pain questionnaire in measuring changes in musculoskeletal pain. J Sport Rehabil 2011; 20 (02) 250-255
  • 18 Cooney WP, Bussey R, Dobyns JH, Linscheid RL. Difficult wrist fractures. Perilunate fracture-dislocations of the wrist. Clin Orthop Relat Res 1987; (214) 136-147
  • 19 Hudak PL, Amadio PC, Bombardier C. The Upper Extremity Collaborative Group (UECG). Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. Am J Ind Med 1996; 29 (06) 602-608
  • 20 Wolfe SW, Hotchkiss RN, Pederson WC, Kozin SH. Green's Operative Hand Surgery. Vol. 2. 6th ed.. Philadelphia, PA: Elsevier; 2010: 2067-2088
  • 21 Harvey FJ, Harvey PM, Horsley MW. De Quervain's disease: surgical or nonsurgical treatment. J Hand Surg Am 1990; 15 (01) 83-87
  • 22 Dean BJ, Lostis E, Oakley T, Rombach I, Morrey ME, Carr AJ. The risks and benefits of glucocorticoid treatment for tendinopathy: a systematic review of the effects of local glucocorticoid on tendon. Semin Arthritis Rheum 2014; 43 (04) 570-576
  • 23 Martinelli N, Marinozzi A, Carnì S, Trovato U, Bianchi A, Denaro V. Platelet-rich plasma injections for chronic plantar fasciitis. Int Orthop 2013; 37 (05) 839-842
  • 24 Kim E, Lee JH. Autologous platelet-rich plasma versus dextrose prolotherapy for the treatment of chronic recalcitrant plantar fasciitis. PM R 2014; 6 (02) 152-158
  • 25 Jeyaraman M. The prospective study on efficacy and functional outcome of autologous platelet rich plasma injection in musculoskeletal disorders. EC Orthopaedics 2018; 9: 849-863
  • 26 Shivanna D, Manjunath D, Holagundi L, Kumar HVM. Outcome of intra-sheath steroid injection for De Quervain's tenosynovitis. The Internet Journal of Hand Surgery 2014; 6 (01) 1-5
  • 27 McDermott JD, Ilyas AM, Nazarian LN, Leinberry CF. Ultrasound-guided injections for de Quervain's tenosynovitis. Clin Orthop Relat Res 2012; 470 (07) 1925-1931
  • 28 Mehdinasab SA, Alemohammad SA. Methylprednisolone acetate injection plus casting versus casting alone for the treatment of de Quervain's tenosynovitis. Arch Iran Med 2010; 13 (04) 270-274